DPAM
UTHR icon

Degroof Petercam Asset Management’s United Therapeutics UTHR Stock Holding History

Degroof Petercam Asset Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$2.57M Sell
11,200
-14,000
-56% -$3.16M 0.03% 293
2023
Q4 		$5.54M Buy
+25,200
New +$5.81M 0.07% 211

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Degroof Petercam Asset Management's UTHR Position: Q1 2024 in Review

Degroof Petercam Asset Management reduced its United Therapeutics (UTHR) stake by 56% in Q1 2024, selling an estimated $3.16M and leaving 11,200 shares worth $2.57M. The position accounts for 0.03% of the portfolio, ranked #293.

Degroof Petercam Asset Management first reported a position in UTHR in Q4 2023 and has held it in 2 quarters since. The position peaked at $5.54M in Q4 2023. 526 funds tracked by Wall St. Rank hold UTHR as of Q1 2024.

  • Degroof Petercam Asset Management held 11,200 shares of United Therapeutics worth $2.57M as of Q1 2024.
  • Degroof Petercam Asset Management sold 14,000 United Therapeutics shares in Q1 2024, an estimated $3.16M.
  • United Therapeutics made up 0.03% of Degroof Petercam Asset Management's portfolio in Q1 2024, its #293 holding.
  • Degroof Petercam Asset Management first reported a position in United Therapeutics in Q4 2023 and has held it in 2 quarters since.
  • Degroof Petercam Asset Management's United Therapeutics position peaked at $5.54M in Q4 2023.
  • 526 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2024.

Based on Degroof Petercam Asset Management's 13F filing for Q1 2024, filed 13 May 2024.